- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Biocon Limited — Updates, 16-10-2025: Press Release
16-10-2025 | 03:50 pm
16-10-2025 | 03:50 pm
Biocon Biologics expanded its Civica partnership, launching private-label Insulin Glargine in the U.S. Biocon will supply, Civica commercializes. This move boosts access to affordable diabetes treatment, strengthening Biocon's market presence.
No comments yet. Be the first to comment!